CHEN Xi, ZHOU Jian-ying, LI Yang-si. Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
|
Citation:
|
CHEN Xi, ZHOU Jian-ying, LI Yang-si. Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
|
CHEN Xi, ZHOU Jian-ying, LI Yang-si. Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
|
Citation:
|
CHEN Xi, ZHOU Jian-ying, LI Yang-si. Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
|
DownLoad: